PTC Therapeutics (PTCT) Prices 8.37M IPO at $15/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall St futures mixed ahead of CPI, bank earnings; US-Iran tensions in focus
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- Goldman Sachs Upgrades NIO (NIO) to Buy
- IBM misses Q2 targets as mainframe and software sales disappoint
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
PTC Therapeutics (PTCT) IPO Opens Higher
June 20, 2013 10:48 AM EDTThe IPO for PTC Therapeutics, Inc. (Nasdaq: PTCT) opened for trading at $15.80 after pricing 8,372,000 shares of common stock at a public offering price of $15.00 per share.
J.P. Morgan and Credit Suisse are acting as joint book-running managers for the IPO.... More
